Key Record Dates
ClinicalTrials.gov Identifier: | NCT03212404 |
---|---|
Brief Title: | Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers |
First Submitted : | July 6, 2017 |
First Submitted that Met QC Criteria : | July 6, 2017 |
First Posted : | July 11, 2017 |
Last Update Submitted that Met QC Criteria : | November 12, 2020 |
Last Update Posted : | November 13, 2020 |